<code id='1EA796E3AF'></code><style id='1EA796E3AF'></style>
    • <acronym id='1EA796E3AF'></acronym>
      <center id='1EA796E3AF'><center id='1EA796E3AF'><tfoot id='1EA796E3AF'></tfoot></center><abbr id='1EA796E3AF'><dir id='1EA796E3AF'><tfoot id='1EA796E3AF'></tfoot><noframes id='1EA796E3AF'>

    • <optgroup id='1EA796E3AF'><strike id='1EA796E3AF'><sup id='1EA796E3AF'></sup></strike><code id='1EA796E3AF'></code></optgroup>
        1. <b id='1EA796E3AF'><label id='1EA796E3AF'><select id='1EA796E3AF'><dt id='1EA796E3AF'><span id='1EA796E3AF'></span></dt></select></label></b><u id='1EA796E3AF'></u>
          <i id='1EA796E3AF'><strike id='1EA796E3AF'><tt id='1EA796E3AF'><pre id='1EA796E3AF'></pre></tt></strike></i>

          explore

          explore

          author:knowledge    Page View:783
          Cambridge: AbbVie
          The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 — nearly a million dollars more than the company has ever spent in a single quarter. Ruby Wallau for STAT

          WASHINGTON — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 alone — more than any other drugmaker spent in the same period, and nearly a million dollars more than the company spent in the same period last year.

          AbbVie was the seventh-highest corporate lobbying spender last quarter, ahead of giants like Lockheed Martin, CVS Health, and, AT&T, federal records show.

          advertisement

          The number is eye-popping even for the pharmaceutical industry, which is known for its omnipresence on Capitol Hill, and its nearly unlimited lobbying budgets.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          leisure time

          Medical leaders decry Supreme Court decision on affirmative action
          Medical leaders decry Supreme Court decision on affirmative action

          STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

          read more
          Baby aspirin cuts fat buildup in liver disease patients, in small study
          Baby aspirin cuts fat buildup in liver disease patients, in small study

          PatrickSison/APLow-doseaspirinledtoareductioninliverfatamongpatientswithmetabolic-associatedliverdis

          read more
          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more

          Novel spinal cord stimulator treats paralysis without surgery

          CourtesyOnwardMedicalAfterhisspinalcordinjuryin2014,SherownCampbellworkedhardtoregainasmuchbodilyfun